Phase 1 Cutaneous T Cell Lymphoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Mycosis FungoidesCutaneous T Cell Lymphoma

University of Alabama at Birmingham10 enrolled1 locationNCT05414500

Recruiting

Phase 1

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

Cutaneous T Cell Lymphoma

H. Lee Moffitt Cancer Center and Research Institute38 enrolled1 locationNCT07047885

Recruiting

Phase 1Phase 2

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more

Ossium Health, Inc.12 enrolled9 locationsNCT05589896